Durabolin 25 mg Injection 1 ml
₹122.4*
MRP ₹136
10% off
₹116*
MRP ₹136
15% CB
₹20 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Durabolin 25 mg Injection 1 ml belongs to the group of medications called ‘anabolic steroids’ used to treat osteoporosis in post-menopausal women. Osteoporosis is a medical condition in which bone becomes thin or weak. When a woman reaches menopause stage, ovaries stop making estrogen, a female hormone responsible for bone health. Due to the deficiency of estrogen, inadequate bone formation occurs, resulting in the weakening of bones. The earlier a woman reaches to her menopause, the more the chances of osteoporosis. This condition can result in brittle or broken bones if prompt treatment is not given.
Durabolin 25 mg Injection 1 ml contains ‘Nandrolone’ which is a steroid used to prevent bone loss. It works by inhibiting bone resorption (breaking down of bone tissue) and promote bone formation. It can effectively delay bone loss.
The common side-effects of Durabolin 25 mg Injection 1 ml are fluid retention in the tissues (swelling of the ankles or feet or increased blood pressure), masculinization (an increase in male characteristics in women) such as a change in voice, hoarseness, increase in body or facial hair or acne, increased libido (sexual desire), nausea and itching. It may also alter blood tests such as increased haemoglobin levels, changes in blood lipids (fats) and liver function tests. Inform your doctor if any of these side-effects persist or worsen.
Do not take Durabolin 25 mg Injection 1 ml if you are allergic to ‘Nandrolone’ or any ingredients such as Arachis oil or peanut oil and benzyl alcohol present in it. It should not be given in conditions such as breast cancer in women with hypercalcemia (high calcium levels in the body), diagnosed or suspected breast cancer in men, kidney diseases and diagnosed or suspected prostate cancer. It should not be used in pregnant or breastfeeding women.
Durabolin 25 mg Injection 1 ml contains 'nandrolone' which is an anabolic steroid. It can effectively treat osteoporosis in postmenopausal women, especially in women with a lean body or muscle mass. It works by inhibiting the breakdown of bone tissue and promoting bone formation. It also increases muscle mass in the body.
Durabolin 25 mg Injection 1 ml may alter haemoglobin levels, so regular monitoring of patients should be required at least once in 3 months in the initial 12 months followed by once in a year till the completion of therapy. Elderly patients should be monitored for calcium levels and the presence of tumours. In patients with heart, kidney, liver diseases, epilepsy (fits), and migraine, there is a risk of oedema or fluid retention. In such cases, treatment should be discontinued immediately.
Drug-Drug Interaction: Durabolin 25 mg Injection 1 ml may enhance the action of anticoagulants. It may also interact with insulin or other oral medications used to treat diabetes and a medication used to treat anaemia (erythropoietin).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: Durabolin 25 mg Injection 1 ml is contraindicated in conditions such as breast cancer in women with hypercalcemia (high calcium levels in the body), diagnosed or suspected breast cancer in men, kidney diseases, porphyria (a group of liver disorders) and diagnosed or suspected prostate cancer.
Osteoporosis: It is a medical condition that causes thinning and weakening of the bones. It usually happens in women after menopause when there is decreased production of estrogen in the body. Estrogen is a female hormone responsible for bone health. Due to a lack of estrogen, the bone starts becoming weaker due to bone loss. The earlier a woman reaches the menopause stage, the greater the chances of osteoporosis. In starting days, osteoporosis does not show any symptoms. However, if proper treatment is not provided, then it can even lead to broken bones. Initially, the bones don't hurt and breaks in the spine's bones may go unseen until they cause height loss. In osteoporosis, bones can break even during daily activities like lifting or even from minor activities. Bones usually occur at the hip, spine or wrist which can even lead to stooped posture (dowager’s hump) and loss of movement.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
Consumption of alcohol may worsen the condition by increasing the risk of side-effects.
Pregnancy
Unsafe
Durabolin 25 mg Injection 1 ml is a category X drug. It is not recommended for use in pregnant women as it may cause birth defects in the fetus.
Breast Feeding
Unsafe
Durabolin 25 mg Injection 1 ml is not recommended for breastfeeding mothers as it may cause harmful effects in nursing babies.
Driving
Safe if prescribed
Durabolin 25 mg Injection 1 ml may not affect your ability to drive.
Liver
Caution
If clinically needed, Durabolin 25 mg Injection 1 ml should be used in patients with liver diseases. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kidney
Caution
Durabolin 25 mg Injection 1 ml should be used in patients with kidney diseases if clinically needed and if your doctor thinks benefits outweigh the risks.
Children
Caution
Durabolin 25 mg Injection 1 ml should be used in children below 12 years of age only if clinically needed and if benefits outweigh the risks.
Product Substitutes